US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares MSCI Pacific ex Japan ETF

51.08

+0.02000.04%

Post-market: 51.080.00000.00%16:10 EST

Volume:299.08K

Turnover:15.30M

Market Cap:1.76B

PE:6.01

High:51.48

Open:51.48

Low:51.02

Close:51.06

52wk High:52.72

52wk Low:38.44

Shares:34.50M

Float Shares:34.50M

Volume Ratio:0.92

T/O Rate:0.87%

Dividend:1.83

Dividend Rate:3.58%

EPS(TTM):8.50

EPS(LYR):8.50

ROE:15.89%

ROA:2.19%

PB:0.96

PE(LYR):6.01

Loading ...

Overview Company News Filings

Concept

ESG ETF-MSCI+0.10%

Capital Flow

Inflow:

Outflow:

News

CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies

EU Moves to Weaken Corporate Sustainability Reporting Rules, Signaling Shift in Green Policy

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

Benzinga_recent_news

Health Canada Extends Review of CLINUVEL’s SCENESSE® for EPP

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EPP"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EPP\",,,,,undefined,":{"symbol":"EPP","market":"US","secType":"STK","nameCN":"iShares MSCI Pacific ex Japan ETF","latestPrice":51.08,"timestamp":1765832400000,"preClose":51.06,"halted":0,"volume":299075,"hourTrading":{"tag":"盘后","latestPrice":51.08,"preClose":51.08,"latestTime":"16:10 EST","volume":9,"amount":459.72,"timestamp":1765833004605},"delay":0,"floatShares":34500000,"shares":34500000,"eps":8.495214,"marketStatus":"Not Yet Opened","change":0.02,"latestTime":"12-15 16:00:00 EST","open":51.48,"high":51.48,"low":51.015,"amount":15302086.9138,"amplitude":0.009107,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":8.495214,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765875600000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":51.06,"sharesOutstanding":34500000,"nav":51.14547,"aum":1764518715,"dividendRate":0.035785,"bidAskSpread":0.000252,"postHourTrading":{"tag":"盘后","latestPrice":51.08,"preClose":51.08,"latestTime":"16:10 EST","volume":9,"amount":459.72,"timestamp":1765833004605},"volumeRatio":0.923245,"impliedVol":0.1561,"impliedVolPercentile":0.944},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EPP\",,,,,undefined,":{"symbol":"EPP","floatShares":34500000,"roa":"2.19%","roe":"15.89%","lyrEps":8.495214,"volumeRatio":0.923245,"shares":34500000,"dividePrice":1.8279,"high":51.48,"amplitude":0.009107,"preClose":51.06,"low":51.015,"week52Low":38.44,"pbRate":"0.96","psRate":"23.05","week52High":52.72,"institutionHeld":0,"latestPrice":51.08,"eps":8.495214,"divideRate":0.035785,"volume":299075,"delay":0,"ttmEps":8.495214,"open":51.48,"prevYearClose":43.81,"prevWeekClose":51.06,"prevMonthClose":50.63,"prevQuarterClose":51.56,"fiveDayClose":50.74,"twentyDayClose":50.87,"sixtyDayClose":51.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EPP\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"EPP","amount":1.045605,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"EPP","amount":0.858764,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"EPP","amount":0.96746,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"EPP","amount":0.70131,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"},{"date":"2023-12-20","symbol":"EPP","amount":0.966028,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"亚太地区（除日本）ETF-iShares MSCI","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EPP\",market:\"US\",,,undefined,":[{"executeDate":"2015-12-21","recordDate":"2015-12-23","paymentDate":"2015-12-28","value":0.927279,"currency":"USD"},{"executeDate":"2016-06-22","recordDate":"2016-06-24","paymentDate":"2016-06-28","value":0.661333,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.90607,"currency":"USD"},{"executeDate":"2017-06-20","recordDate":"2017-06-22","paymentDate":"2017-06-26","value":0.756156,"currency":"USD"},{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-25","value":0.867553,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EPP\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EPP\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2589388874","title":"CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2589388874","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589388874?lang=en_us&edition=fundamental","pubTime":"2025-12-08 10:37","pubTimestamp":1765161420,"startTime":"0","endTime":"0","summary":"CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies   CLINUVEL expands Singapore RD&I Centre to pioneer next-generation peptide therapies   CLINUVEL expands Singapore R","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/08/3201174/0/en/CLINUVEL-expands-Singapore-RD-I-Centre-to-pioneer-next-generation-peptide-therapies.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4582","EPP"],"gpt_icon":0},{"id":"1182813551","title":"EU Moves to Weaken Corporate Sustainability Reporting Rules, Signaling Shift in Green Policy","url":"https://stock-news.laohu8.com/highlight/detail?id=1182813551","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182813551?lang=en_us&edition=fundamental","pubTime":"2025-11-14 08:42","pubTimestamp":1763080936,"startTime":"0","endTime":"0","summary":"A vote in the European Parliament to relax corporate environmental, social, and governance (ESG) reporting obligations is being interpreted as a strong signal that the EU is shifting its policy focus...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ESG","EPP","BK4582"],"gpt_icon":0},{"id":"2576505986","title":"FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times","url":"https://stock-news.laohu8.com/highlight/detail?id=2576505986","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576505986?lang=en_us&edition=fundamental","pubTime":"2025-10-17 22:03","pubTimestamp":1760709780,"startTime":"0","endTime":"0","summary":"The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, and other conditions.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/17/lab--Medical-Hospital-Research-Laborator.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/17/lab--Medical-Hospital-Research-Laborator.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/fda/25/10/48275103/fda-unveils-first-experimental-drugs-under-fast-track-voucher-plan-to-cut-drug-review-times","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/fda/25/10/48275103/fda-unveils-first-experimental-drugs-under-fast-track-voucher-plan-to-cut-drug-review-times","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LU0823434740.USD","LU0053666078.USD","LU2237438978.USD","LU2468319806.SGD","BK4585","MNQmain","BK4567","PSQ","BK4007","USJW.SI","SNY","IE00BFXG0V08.USD","LU2362540622.SGD","IRON","BK4139","EPP","ACHV","LU0823416689.USD","LU2089984988.USD","TQQQ","BK4582","IE00BYQQ9H92.USD","NVIW.SI","LU0889565916.HKD","LU2106854487.HKD","SQQQ","LU0109394709.USD","LU0823434583.USD","LU2362541513.USD","IE00B5TLWC47.USD",".IXIC","REGN","RVMD","NQmain","BK4588","LU0882574055.USD","QID","LU2023250504.SGD","LU0320765992.SGD","LU1974910355.USD","LU0289739699.SGD","LU1917777945.USD","FAST","TSYW.SI","USAW.SI","XLP","QLD","IE00BFXG1179.USD","LU0058720904.USD"],"gpt_icon":1},{"id":"2575760584","title":"Health Canada Extends Review of CLINUVEL’s SCENESSE® for EPP","url":"https://stock-news.laohu8.com/highlight/detail?id=2575760584","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575760584?lang=en_us&edition=fundamental","pubTime":"2025-10-16 10:47","pubTimestamp":1760582871,"startTime":"0","endTime":"0","summary":"Clinuvel Pharmaceuticals ( ($AU:CUV) ) just unveiled an update. CLINUVEL Pharmaceuticals announced that Health Canada has requested additional time...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/health-canada-extends-review-of-clinuvels-scenesse-for-epp?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/health-canada-extends-review-of-clinuvels-scenesse-for-epp?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4582","EPP"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":10,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EPP\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ESG ETF-MSCI","bkCode":"BK4582","id":"package_us_concept_esgetfmsci","changeRate":0.001038}]}}